- Home
- VSCO vs BCRX Comparison
VSCO vs BCRX Comparison
Compare VSCO & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSCO
- BCRX
- Stock Information
- Founded
- VSCO 1977
- BCRX 1986
- Country
- VSCO United States
- BCRX United States
- Employees
- VSCO N/A
- BCRX N/A
- Industry
- VSCO Clothing/Shoe/Accessory Stores
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VSCO Consumer Discretionary
- BCRX Health Care
- Exchange
- VSCO Nasdaq
- BCRX Nasdaq
- Market Cap
- VSCO 2.1B
- BCRX 1.8B
- IPO Year
- VSCO N/A
- BCRX 1994
- Fundamental
- Price
- VSCO $26.28
- BCRX $7.75
- Analyst Decision
- VSCO Hold
- BCRX Strong Buy
- Analyst Count
- VSCO 12
- BCRX 10
- Target Price
- VSCO $26.08
- BCRX $16.70
- AVG Volume (30 Days)
- VSCO 3.4M
- BCRX 2.3M
- Earning Date
- VSCO 08-28-2025
- BCRX 11-03-2025
- Dividend Yield
- VSCO N/A
- BCRX N/A
- EPS Growth
- VSCO 6.76
- BCRX N/A
- EPS
- VSCO 1.86
- BCRX N/A
- Revenue
- VSCO $6,265,000,000.00
- BCRX $557,506,000.00
- Revenue This Year
- VSCO $3.84
- BCRX $41.34
- Revenue Next Year
- VSCO $2.44
- BCRX $6.11
- P/E Ratio
- VSCO $14.24
- BCRX N/A
- Revenue Growth
- VSCO 2.29
- BCRX 45.85
- 52 Week Low
- VSCO $13.76
- BCRX $6.02
- 52 Week High
- VSCO $48.73
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- VSCO 62.02
- BCRX 50.07
- Support Level
- VSCO $25.84
- BCRX N/A
- Resistance Level
- VSCO $28.06
- BCRX $8.13
- Average True Range (ATR)
- VSCO 1.32
- BCRX 0.19
- MACD
- VSCO 0.23
- BCRX -0.33
- Stochastic Oscillator
- VSCO 71.05
- BCRX 89.29
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.